Kelly Culwell, Chief Medical Officer at Evofem Biosciences, Inc. (EVFM), bought 3,000 shares at $2.24 ($7K) on 2018-08-16, disclosed to the SEC on 2018-08-20.
Open-market purchase of $7k EVFM by Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| EVFM | SELL | 2019-12-04 | $7K | — | Filing → |